1. Home
  2. Analysis
  3. Revlimid
  4. Urge-incontinence

Revlimid and Urge incontinence - a phase IV clinical study of FDA data

Summary:

Urge incontinence is reported as a side effect among people who take Revlimid (lenalidomide), especially for people who are female, 50-59 old, also take Florinef, and have Light chain analysis increased.

The phase IV clinical study analyzes which people have Urge incontinence when taking Revlimid. It is created by eHealthMe based on reports of 377,717 people who have side effects when taking Revlimid from the FDA, and is updated regularly.

What is Revlimid?

Revlimid has active ingredients of lenalidomide. It is often used in multiple myeloma. eHealthMe is studying from 378,026 Revlimid users. Check the latest studies of Revlimid.

What is Urge incontinence?

Urge incontinence (urinary incontinence) is found to be associated with 219 drugs and 596 conditions by eHealthMe. Check the latest studies of Urge incontinence.

On Jul, 15, 2026

377,717 people reported to have side effects when taking Revlimid.
Among them, 21 people (0.01%) have Urge incontinence.

Could Revlimid cause Urge incontinence?

Among these 21 people:

What is the gender of people who have Urge incontinence when taking Revlimid? *

  • female: 85.71 %
  • male: 14.29 %

What is the age of people who have Urge incontinence when taking Revlimid? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 5.56 %
  • 40-49: 22.22 %
  • 50-59: 66.67 %
  • 60+: 5.56 %

What are other drugs people take besides Revlimid? *

  1. Levaquin: 12 people, 57.14%
  2. Ditropan Xl: 12 people, 57.14%
  3. Midodrine Hydrochloride: 12 people, 57.14%
  4. Macrobid: 12 people, 57.14%
  5. Lotrel: 12 people, 57.14%
  6. Lexapro: 12 people, 57.14%
  7. Zoloft: 12 people, 57.14%
  8. Flutamide: 12 people, 57.14%
  9. Fludrocortisone Acetate: 12 people, 57.14%
  10. Florinef: 12 people, 57.14%

What are other side effects people have besides Urge incontinence? *

  1. Osteonecrosis Of Jaw (death of bone of jaw): 17 people, 80.95%
  2. Pain: 17 people, 80.95%
  3. Dyspnea (difficult or laboured breathing): 17 people, 80.95%
  4. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 17 people, 80.95%
  5. Depression: 17 people, 80.95%
  6. Stress And Anxiety: 17 people, 80.95%
  7. Osteoarthritis (a joint disease caused by cartilage loss in a joint): 17 people, 80.95%
  8. Infection: 16 people, 76.19%
  9. Injury: 16 people, 76.19%
  10. Fall: 15 people, 71.43%

What are the existing conditions these people have? *

  1. Light Chain Analysis Increased: 12 people, 57.14%

* Approximation only. Some reports may have incomplete information.

Do you take Revlimid and have Urge incontinence?

- Check whether Urge incontinence is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Revlimid:

Urge incontinence treatments and more:

How severe was Urge incontinence and when was it recovered:

Expand to all the drugs that have ingredients of lenalidomide:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Revlimid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Urge incontinence:

Browse all the conditions that are associated with Urge incontinence:

How the study uses the data?

The study uses data from the FDA. It is based on lenalidomide (the active ingredients of Revlimid) and Revlimid (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.